Predicting Early Readmission Following PCI: A Work in Progress
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27070
Abstract: Early hospital readmissions after percutaneous coronary interventions (PCI) are common and costly. From the NCDR CathPCI Registry and the Centers for Medicare and Medicaid Services, a risk prediction model was generated using 14 clinical variables,… read more here.
Keywords: following pci; work progress; predicting early; pci work ... See more keywords
Five years in, Paris pact still a work in progress.
Sign Up to like & getrecommendations! Published in 2020 at "Science"
DOI: 10.1126/science.370.6523.1390
Abstract: Five years after the Paris international climate agreement, many countries are falling short of their promises, and of the greenhouse gas cuts needed to stave off the worst effects of climate change. More than 70… read more here.
Keywords: paris pact; work progress; five years; pact still ... See more keywords
Equality as a work in progress
Sign Up to like & getrecommendations! Published in 2023 at "Science"
DOI: 10.1126/science.adg2268
Abstract: Description History shows that neither patriarchy nor parity is inevitable History shows that neither patriarchy nor parity is inevitable read more here.
Keywords: work progress; equality work;
Management of Mycotic Aortic Aneurysms: Work in Progress
Sign Up to like & getrecommendations! Published in 2020 at "Angiology"
DOI: 10.1177/0003319720904508
Abstract: Cullen et al report the outcomes of 38 patients with mycotic aortic aneurysms (MAAs) offered endovascular repair (n 1⁄4 21), open surgery (n 1⁄4 10), or medical therapy alone (n 1⁄4 7). Median (range) survival… read more here.
Keywords: aneurysms work; mycotic aortic; work progress; aortic aneurysms ... See more keywords
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29100626
Abstract: Cholangiocarcinoma (CCA) is the second most frequent primary liver cancer, following hepatocellular carcinoma (HCC). Progress in the molecular understanding of CCA has led to the development of several agents, including FGFR inhibitors, such as pemigatinib,… read more here.
Keywords: intrahepatic cholangiocarcinoma; progress; cholangiocarcinoma; work progress ... See more keywords